Individualised treatment effects of corticosteroids in IgA nephropathy
David L. Hölscher, Nikolas E.J. Schmitz, Leon Niggemeier, Pourya Pilva et autres
BACKGROUND: IgA nephropathy (IgAN) has diverse clinical presentations and responses to treatment. For systemic corticosteroids in particular, randomised controlled trials have reported conflicting effects, highlighting the need for individualised treatment strategies. METHODS: In this retrospective cohort study, we derived and validated a …
de, cz, gb, it, us, jp, tr (code pays fourni par la source)